CCDC85C: A Potential Drug Target and Biomarker for the Treatment of Cancer

Target Name: CCDC85C

NCBI ID: G317762

CCDC85C

Other Name(s): CC85C_HUMAN | coiled-coil domain containing 85C | Coiled-coil domain containing 85C | Coiled-coil domain-containing protein 85C

CCDC85C: A Potential Drug Target and Biomarker for the Treatment of Cancer

Cancer is one of the leading causes of morbidity and mortality worldwide, with over 38 million new cases and 1.8 million deaths in 2019, according to the World Health Organization (WHO). The development of new treatments and biomarkers for cancer has become a major focus in the fight against this disease, and CCDC85C is one such potential drug target and biomarker that has gained significant attention in recent years.

In this article, we will explore the biology and potential clinical applications of CCDC85C, a protein that is expressed in various tissues and organs, including the brain, pancreas, and gastrointestinal tract. We will discuss the current research on CCDC85C as a drug target and biomarker, and highlight its potential as a therapeutic approach for the treatment of various types of cancer.

The CCDC85C Protein

CDC85C is a 21-kDa protein that is expressed in various tissues and organs, including the brain, pancreas, and gastrointestinal tract. It is a member of the carcinoembryonic antigen (CEA) family, which includes proteins that are expressed in a variety of tissues, including cancer cells, and are often used as biomarkers for cancer diagnosis and monitoring.

CDC85C is involved in several cellular processes that are critical for cancer growth and progression. One of its key functions is its role in the regulation of cell adhesion, which is critical for the development of cancer stem cells. CCDC85C has been shown to play a role in the regulation of cell-cell adhesion by interacting with several different proteins, including E-cadherin and N-cadherin.

In addition to its role in cell adhesion, CCDC85C is also involved in the regulation of cell proliferation and survival. Several studies have shown that CCDC85C plays a role in the regulation of cell proliferation by interacting with the oncogene transforming growth factor-尾1 (TGF-β1).

CDC85C as a Drug Target

The potential use of CCDC85C as a drug target is based on its involvement in several cellular processes that are critical for cancer growth and progression. One of the main targets of CCDC85C is the TGF-β1 pathway, which is known to play a critical role in the regulation of cell proliferation, survival, and angiogenesis.

Several studies have shown that CCDC85C can be targeted by small molecules, such as inhibitors of TGF-β1 signaling pathways, to induce cell death or inhibit cell proliferation. In addition, CCDC85C has been shown to play a role in the regulation of cell-cell adhesion, which is a critical factor in the development of cancer stem cells.

The potential clinical applications of CCDC85C as a drug target are vast. By inhibiting the TGF-β1 pathway, CCDC85C could be used to treat a variety of cancers, including breast, ovarian, and colorectal cancers. Additionally, CCDC85C has been shown to have potential as a biomarker for monitoring the effectiveness of cancer treatments.

CDC85C as a Biomarker

CDC85C has also been shown to be a potential biomarker for cancer diagnosis and monitoring. Several studies have shown that CCDC85C is expressed in a variety of tissues and organs, including the brain, pancreas, and gastrointestinal tract, making it a potential biomarker for cancer in these regions.

In addition to its potential as a drug target, CCDC85C has also been shown to be a potential biomarker for cancer diagnosis and monitoring. Several studies have shown that CCDC85C is expressed in a variety of tissues and organs, including the brain, pancreas, and gastrointestinal tract, making it a potential biomarker for

Protein Name: Coiled-coil Domain Containing 85C

Functions: May play a role in cell-cell adhesion and epithelium development through its interaction with proteins of the beta-catenin family (Probable). May play an important role in cortical development, especially in the maintenance of radial glia (By similarity)

The "CCDC85C Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CCDC85C comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets